ezetimibe has been researched along with 8-epi-prostaglandin f2alpha in 2 studies
| Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (8-epi-prostaglandin f2alpha) | Trials (8-epi-prostaglandin f2alpha) | Recent Studies (post-2010) (8-epi-prostaglandin f2alpha) |
|---|---|---|---|---|---|
| 2,484 | 563 | 1,465 | 1,863 | 248 | 723 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elisaf, M; Gazi, IF; Kostapanos, MS; Liberopoulos, EN; Spyrou, AT; Tellis, CC; Tselepis, AD | 1 |
| Elisaf, MS; Liberopoulos, EN; Milionis, HJ; Moutzouri, E; Tellis, CC; Tselepis, AD | 1 |
2 trial(s) available for ezetimibe and 8-epi-prostaglandin f2alpha
| Article | Year |
|---|---|
Ezetimibe treatment lowers indicators of oxidative stress in hypercholesterolemic subjects with high oxidative stress.
Topics: Aged; Anticholesteremic Agents; Azetidines; Biomarkers; Dinoprost; Ezetimibe; Humans; Hypercholesterolemia; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress | 2011 |
Comparison of the effect of simvastatin versus simvastatin/ezetimibe versus rosuvastatin on markers of inflammation and oxidative stress in subjects with hypercholesterolemia.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Aged; Azetidines; Cholesterol, LDL; Dinoprost; Drug Combinations; Ezetimibe; Female; Fluorobenzenes; Humans; Hypercholesterolemia; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress; Pyrimidines; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2013 |